synedica | Retatrutide 40mg

synedica retatrutide 40mg  | Synedica

synedica , Triple agonist of GLP-1, GIP, and glucagon receptors. The most advanced weight loss compound available, suppressing appetite while boosting metabolic rate simultaneously.

Retatrutide has become a significant subject within contemporary peptide and metabolic research because of its activity across three receptor pathways: GIP, GLP-1 and glucagon. This combination distinguishes retatrutide from compounds that act primarily through one or two of these pathways and has made the molecule an important subject of scientific investigation.